26
Participants
Start Date
December 31, 2000
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
Pioglitazone
This was a randomized placebo-controlled crossover study in which subjects received both agents in random order, separated by a wash-out period. Following 10 or 21 days' intervention, subjects underwent a pancreatic clamp study.
Placebo
This was a randomized placebo-controlled crossover study in which subjects received both agents in random order, separated by a wash-out period. Following 10 or 21 days' intervention, subjects underwent a pancreatic clamp study.
Pancreatic Clamp Study
During the clamp procedure, glucose (a sugar) and insulin were infused with an IV catheter, and blood samples were collected periodically throughout the procedure to measure blood sugar levels and the levels of several hormones that are found in the body and are related to glucose metabolism.
Albert Einstein College of Medicine, The Bronx
Collaborators (1)
Takeda
INDUSTRY
Albert Einstein College of Medicine
OTHER